quatrx.com Pages on BioPortfolio:

BioPortfolio - QUATRx Pharmaceuticals - Profile
View the current QUATRx Pharmaceuticals Page on BioPortfolio.com ... QUATRx is building a portfolio of novel drug opportunities in a variety of therapeutic ...
http://www.bioportfolio.com/biocorporate/8714-QUATRx%2BPharm...

BioPortfolio - QuatRx Pharmaceuticals - Profile
View the current QuatRx Pharmaceuticals Page on BioPortfolio.com ... QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, ...
http://www.bioportfolio.com/biocorporate/28945-QuatRx+Pharma...

BioPortfolio - Biocorporate Search Ann Arbor
QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the
endocrine, ...
http://www.bioportfolio.com/biocorporate/search/city/Ann%20A...

BioPortfolio - Biocorporate Search Endocrine1
QUATRx is building a portfolio of novel drug opportunities in a variety of therapeutic areas through in-licensing. Through the application of novel ...
http://www.bioportfolio.com/biocorporate/Endocrine-companies...

BioPortfolio - Biocorporate Search MI
QuatRx Pharmaceuticals Company is a pharmaceutical company focused on ... QUATRx is building a portfolio of novel drug opportunities in a variety of ...
http://www.bioportfolio.com/biocorporate/search/region/MI.ht...

BioPortfolio - Hormos Medical Corporation - Profile
QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena( TM) · (Ospemifene Tablets) Showin. KRON4: Sep 25 2008 1:54AM Matching: hormos
...
http://www.bioportfolio.com/biocorporate/5041-Hormos+Medical...

Results from other life science and pharmaceutical sites:

QuatRx Pharmaceuticals Announces Positive Phase 3 Results for ...
3 /PRNewswire/ -- QuatRx Pharmaceuticals Company today announced positive results from a pivotal Phase 3 study of Ophena(TM) (ospemifene) to treat ...
http://www.biospace.com/news_story.aspx?NewsEntityId=81660...

Phase 1 Studies Show Promise of QuatRx Pharmaceuticals' Novel ...
29 /PRNewswire/ -- QuatRx Pharmaceuticals, a privately-held biopharmaceutical company developing compounds for the treatment of major endocrine, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=84125...

QuatRx Pharmaceuticals Announces Additional Data From Phase 3 ...
Results were announced today by QuatRx Pharmaceuticals in a poster presentation at the 19th Annual North American Menopause Society meeting in Orlando, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=110860...

August Watanabe, M.D., Elected to Board of Directors Of QuatRx ...
22 /PRNewswire/ -- QuatRx Pharmaceuticals Company, a private biopharmaceutical development company focused on endocrine, metabolic, and cardiovascular ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

QuatRx Pharmaceuticals Reports Positive Results From A Phase 2 ...
8 /PRNewswire/ -- QuatRx Pharmaceuticals today announced positive results from its Phase 2 clinical study of fispemifene in men with low testosterone levels
...
http://www.biospace.com/news_story.aspx?NewsEntityId=41908...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.